Sub menu

 
 

Public submissions on scheduling matters referred to the ACMS #24 and Joint ACMS-ACCS #19 meetings held in June 2018

Scheduling of medicines and poisons
Published

Public submissions made in response to:

On this page: Public submissions on proposed amendments referred to an expert advisory committee | Public submissions on interim decisions

Public submissions on proposed amendments referred to an expert advisory committee

13 September 2018

Public submissions on proposed amendments referred to the ACMS #24

How to access a pdf document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open it from there.

Open all | Close all

Public submissions on proposed amendments referred to the Joint ACMS-ACCS #19

No public submissions were received.

No public submissions were received.

  • Industry stakeholder - The submitter did not give permission to publish their name or submission

Public submissions on interim decisions

30 November 2018

Public submissions made in response to the delegates' interim decision on alkyl nitrites and invitation to comment published on 10 September 2018 and received before the second closing date under regulation 42ZCZP of the Regulations.

Alkyl nitrites

  • Private individual - The submitter did not give permission to publish their name or submission.
  • Private individual - The submitter did not give permission to publish their name or submission.
  • Private individual - The submitter did not give permission to publish their name or submission.
  • Private individual - The submitter did not give permission to publish their name or submission.
  • Private individual - The submitter did not give permission to publish their name or submission.
  • Private individual - The submitter did not give permission to publish their name or submission.
  • Private individual - The submitter did not give permission to publish their name or submission.
  • Private individual - The submitter did not give permission to publish their name or submission.
  • Private individual - The submitter did not give permission to publish their name or submission.
  • Private individual - The submitter did not give permission to publish their name or submission.
  • Private individual - The submitter did not give permission to publish their name or submission.
  • Private individual - The submitter did not give permission to publish their name or submission.
  • Private individual - The submitter did not give permission to publish their name or submission.
  • Private individual - The submitter did not give permission to publish their name or submission.
  • Private individual - The submitter did not give permission to publish their name or submission.
  • Private individual - The submitter did not give permission to publish their name or submission.

Public submissions on interim decisions

17 December 2018

Public submissions made in response to the delegates' interim decisions and invitation to comment published on 10 September 2018 and received before the second closing date under regulation 42ZCZP of the Regulations.

Public submissions on interim decisions following the ACMS #24

Sildenafil

Budesonide

Codeine

  • No public submissions were received.

Cannabidiol and tetrahydrocannabinols

  • Private individual - The submitter did not give permission to publish their name or submission
  • Private individual - The submitter did not give permission to publish their name or submission

Ibuprofen combined with paracetamol

Public submissions on interim decisions following the Joint ACMS-ACCS #19

2-Butoxyethanol

  • No public submissions were received.

Dimethyl sulfoxide

  • No public submissions were received.

Aliphatic allyl esters

Astodrimer sodium

Supporting documents

Topics
Outcome of

Help us improve the Therapeutic Goods Administration site